glp-1 food trends news ranks as No. 1 health trend for 2026 The GLP-1 Boom Is Rewriting

Additional labeled risks include gallbladder disease, acute kidney injury (particularly with severe gastrointestinal adverse events), and potential worsening of diabetic retinopathy complications with semaglutide

For others, it could mean staying on the lowest dose of a GLP-1 medication instead of gradually increasing, deviating from what the clinical trials indicate is needed for weight loss and lower than the doses approved for weight maintenance by the FDA, says Nidhi Kansal, MD , an internal medicine specialist at Northwestern Medical Group

Breath alcohol was measured every 30 minutes, blood glucose was measured twice, and three hours after the session participants again answered subjective questions

Also, DWAT is a source of estrogen production and treatment with GLP-1RA reduces those aging protective hormones due to DWAT loss [13] (Fig

149 (4), 700e710e

Kurokawa, S., Bellinger, F